|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005767,
umls-concept:C0006463,
umls-concept:C0009647,
umls-concept:C0010583,
umls-concept:C0015133,
umls-concept:C0023467,
umls-concept:C0040808,
umls-concept:C0332835,
umls-concept:C0376152,
umls-concept:C0472699,
umls-concept:C0920321,
umls-concept:C1456649,
umls-concept:C1513822,
umls-concept:C1521725,
umls-concept:C1880171
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-10-18
|
|
pubmed:abstractText |
Hematopoietic stem cell transplantation (HSCT) is an important treatment modality for children with AML. The optimal conditioning regimen is unknown. The aim of this study was to determine the appropriate dosing of etoposide in combination with busulfan and cyclophosphamide in this setting.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0098-1532
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2000 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
403-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11025470-Adolescent,
pubmed-meshheading:11025470-Alberta,
pubmed-meshheading:11025470-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11025470-Busulfan,
pubmed-meshheading:11025470-Child,
pubmed-meshheading:11025470-Child, Preschool,
pubmed-meshheading:11025470-Cyclophosphamide,
pubmed-meshheading:11025470-Disease-Free Survival,
pubmed-meshheading:11025470-Drug Administration Schedule,
pubmed-meshheading:11025470-Etoposide,
pubmed-meshheading:11025470-Female,
pubmed-meshheading:11025470-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:11025470-Humans,
pubmed-meshheading:11025470-Infant,
pubmed-meshheading:11025470-Leukemia, Myeloid, Acute,
pubmed-meshheading:11025470-Male,
pubmed-meshheading:11025470-Missouri,
pubmed-meshheading:11025470-Texas,
pubmed-meshheading:11025470-Transplantation Conditioning,
pubmed-meshheading:11025470-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium.
|
|
pubmed:affiliation |
UT Southwestern Medical School and Children's Hospital of Dallas, Dallas, Texas, USA. esandler@nemours.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase I
|
